Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis
Status:
Not yet recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
The goal of this randomized controlled trial is to compare the efficacy and safety of
branched-chain amino acids (BCAA) versus placebo for treating muscle cramps in cirrhotic
patients. The main questions it aims to answer are:
- Compared the effect of BCAA versus placebo on muscle cramp frequency in cirrhotic
patients
- Compared the effect of BCAA versus placebo on muscle cramp duration and severity in
cirrhotic patients
- Compared the effect of BCAA versus placebo on quality of life in cirrhotic patients with
muscle cramps Participants with cirrhosis who have experienced muscle cramps at least
once per week will be randomized to receive either a placebo or 12.45 grams of BCAA
orally per day for 12 weeks.